ClinicalTrials.govpublic full text
Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients
hematologic disorders and bone marrow failure, hematopoietic stem cell transplantation (hsct) or cellular therapy (cart), vaccine, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906000
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.